Asbestos disease projections too lowApril 03, 2007Current predictions of the future incidence of asbestos-related disease have been substantially underestimated, according to new modelling to be presented in Melbourne today by an epidemiologist from The Australian National University. The analysis by Dr Mark Clements, from the National Centre for Epidemiology and Population Health, and colleagues shows that the peak number of cases of mesothelioma, a deadly cancer caused by asbestos, will occur four years later and the future total incidence may be in excess of 35 per cent higher than existing models would have predicted. The pattern for mesothelioma reflects changes in asbestos exposure and therefore reflects predictions for all asbestos-related diseases, Dr Clements said. These early results have important implications for asbestos-related disease liability schemes, Dr Clements said, although more detailed work is needed to properly integrate other factors related to the actuarial implications.
According to the research, an existing model developed by the auditing firm KPMG gave the peak of mesothelioma cases as occurring in 2010, with 3530 cases in New South Wales men. However, Dr Clements said their own epidemiological model showed that the peak could occur as late as 2017 and see 6430 cases of the deadly disease in NSW men. "There is reasonable evidence that the peak of mesothelioma incidence is later than 2010. This has far reaching consequences for actuarial predictions, where the number of cases out to 2060 may be in excess of 35 per cent higher than the number predicted by KPMG's model," he said. "It is unclear why the two models give different results. The KPMG modeling may have been influenced by a common belief that peak incidence would be in 2010; in contrast, our epidemiological model is able to predict the peak for incidence." "Although these results have implications for liability, there are several steps between predicting mesothelioma incidence and calculating liability," he said. "Moreover, modelling would be required for other asbestos-related diseases. "I can't speculate as to the revised level of liability. However based on our modelling of future mesothelioma incidence it's worrying that the liability may have been under-estimated," Dr Clements said. Dr Clements will present this paper at the Accident Compensation Seminar, hosted by the Institute of Actuaries of Australia, in Melbourne today. Research Australia | |||||||||||||||||||||
|
Related Asbestos Current Events and Asbestos News Articles Nanoparticles trigger cell death? Nanoparticles that are one milliard of a metre in size are widely used, for example, in cosmetics and food packaging materials. Jefferson Department of Surgery announces new pancreas tumor registry Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR). Creating lung cancer risk models for specific populations refines prediction Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research. Exposure to Agent Orange linked to prostate cancer in Vietnam veterans UC Davis Cancer Center physicians today released results of research showing that Vietnam War veterans exposed to Agent Orange have greatly increased risks of prostate cancer and even greater risks of getting the most aggressive form of the disease as compared to those who were not exposed. New clinical trial for patients with asbestos-associated lung cancer The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos. New research group offers hope to asbestosis sufferers The Asbestos Research Group, offering hope to sufferers of asbestos-related diseases, was launched at The Wesley Research Institute today. Biomarkers identified for idiopathic pulmonary fibrosis The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science. Low exposure to asbestos-like mineral from Montana vermiculite may up lung disease risk Workers exposed to low levels of an asbestos-like mineral from Montana more than two decades ago are at an increased risk for lung disease today, according to research from the University of Cincinnati (UC). Legal exposure to asbestos-like material linked to lung damage 25 years later Men and women who worked in a plant that processed vermiculite tainted with asbestos-like fibers that originated from a mine in Libby, Montana, show high prevalence of scarring and thickening of the membrane that lines the chest wall some 25 years after the plant stopped using the material-even those who were exposed at or below current legal levels. Lung cancer rates higher among female nonsmokers than previously Not all lung cancer is due to a lifetime of smoking cigarettes. Sometimes the diagnosis is a mystery, and the stigma surrounding the disease makes it hard for patients to talk about. More Asbestos Current Events and Asbestos News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||